• EN

IPA3 project

IPA 3 beneficiaries are Albania, Bosnia-Herzegovina, Croatia, former Yugoslav Republic of Macedonia, Kosovo (under UNSCR 1244/99), Montenegro, Serbia and Turkey.

Timetable: December 2009–November 2011.

Objective of the IPA 3 project is to prepare IPA beneficiaries for their participation in the EMCDDA and to further strengthen the capacity of IPA Beneficiaries to establish, at national level, a drug information system compatible with EMCDDA standards.

Specific objectives identified are:

  • Specific objective I — to provide support to the establishment/strengthening of a national focal point and its future integration in the Reitox network
  • Specific objective II — to provide direct support to data collection/implementation of the national reporting packages (i.e. data collection activities)
  • Specific objective III — to establish/strengthen the institutional relationship with partner countries, in liaison with EU institutions and International Organisations.

Key outputs will be:

  • updated country overview on the drugs situation
  • updated information map
  • a NAPDIS
  • a Recommendation/(draft) decision for a NFP.


2011 multi-country activities

  • IPA Coordination Meeting, 18–20 January 2011, Lisbon, Portugal
  • Reitox Academy for IPA beneficiaries: National Reporting and Quality Assurance, 19 January 2011, Lisbon, Portugal
    The Academy aimed to provide feedback to IPA3 countries on the products developed within the framework of the IPA3 project and to link these products to the national reporting guidelines; and to discuss EMCDDA national reporting guidelines and its applicability to the IPA beneficiaries for the 2011 reporting cycle year. A total of nine representatives from Albania, Bosnia and Herzegovina, Croatia, the former Yugoslav Republic of Macedonia, Kosovo (under UNSCR1244/99), Montenegro, Serbia and Turkey and seven Reitox coaches from EU Member States attended the training and shared their experiences on national reporting practices. The Agenda is available here (link).
  • June coordination meeting: Reitox Academy for IPA beneficiaries: New psychoactive substances and the Early-warning system, 14–15 September, Tirana, Albania
    The Early-warning system is one of the core areas of the EMCDDA activities established by Council Decision 2005/387/JHA of 10 May 2005 and calls for the information exchange, risk assessment and control of new psychoactive substances. This Academy aimed to explain the implementation framework of the Council Decision; to introduce the concept of new psychoactive substances, including the risk assessment process; and to provide knowledge and skills necessary to participate in the EWS network. A total of 18 representatives from all IPA beneficiary countries attended the meeting. The Evaluation report is available here (link).
  • Regional Reitox Academy for IPA beneficiaries: Monitoring and reporting on drug-related death, 27 September 2011, Skopje, former Yugoslav Republic of Macedonia
    Drug-related deaths is one of five key epidemiological indicators for monitoring the drug situation in the European Union. The Academy aimed to explain  the EMCDDA standard protocol for Drug-related death data collection; and to discuss the practices for drug-related death data collection in Candidate and Potential Candidate Countries to propose steps how to align their drug-related death monitoring practices with the standard protocol. A total of 26 participants from the IPA Beneficiaries countries attended the Academy: one from Albania, Bosnia and Herzegovina, Serbia and 23 from the former Yugoslav Republic of Macedonia (the latter was the host country). The Evaluation report is available here (link).
  • IPA–EMCDDA Scientific Closing Seminar: Building national and regional drug monitoring systems in Candidate and Potential Candidate countries, 3–4 October 2011, Brussels, Belgium
    The objective of this Closing Seminar was twofold: to draw on the conclusions and activities implemented during the 24-months project, in line with its main objective and three specific objectives, as well as to give the opportunity to the IPA Beneficiaries countries to present key research activities undertaken in the main areas of work of the EMCDDA, thanks to the support of the IPA project. A total of 64 participants from the IPA Beneficiaries countries, the Permanent mission in Brussels, the European Commission and the EMCDDA attended the closing seminar.

Main outputs

  • Updated/or first national country overviews
  • Updated/or first national information maps
  • National action plan on drug information systems (2009–11)
  • National reports on the drug situtation (2011)
  • School surveys on alcohol and other drugs (ESPAD) in Kosovo (under UNSCR 1244/99)
  • Estimating problem drug use in Ankara and Izmir (Turkey)
  • Survey on substance use among the general population in Croatia
  • Evaluation of the national strategy on combating drug abuse in Croatia 2006–12
  • EMCDDA protocols, guidelines and key reports translated in national languages.

Page last updated: Tuesday, 04 September 2012